Recombinant Anti-TNFRSF8 × Anti-ERBB2 Bispecific Antibody (CrossMab) (CAT#: BSAB-LC004)
The anti-CD30/erbB2 antibody is a "Knobs-into-holes" antibody specifically binding to CD30 and erbB2.By recruiting a toxic activity, the bispecific antibody can be potentially used in the treatment of inflammatory disease.
Specific Inquiry
Specifications
- Target
- CD30 & ErbB2
- Type
- CrossMab
- Species Reactivity
- Human
- Target 1
- CD30
- Host Species 1
- Mouse
- Target 2
- ErbB2
- Host Species 2
- Human
- Application
- ELISA
- Related Disease
- Inflammatory disease
Target
- Target 1
- CD30
- Gene ID
- 943
- UniProt ID
- A5D8T4
- Alternative Names
- TNFRSF8; tumor necrosis factor receptor superfamily, member 8; CD30; Ki-1; D1S166E; tumor necrosis factor receptor superfamily member 8; Ki-1 antigen; CD30L receptor; cytokine receptor CD30; lymphocyte activation antigen CD30;
- Target 2
- ErbB2
- Gene ID
- 2064
- UniProt ID
- P04626
- Alternative Names
- ERBB2; erb-b2 receptor tyrosine kinase 2; EU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for BSAB-LC004. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: ELISA, IHC, FC, WB, IF, IA
-1.jpg)
-1.jpg)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
